Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Therapeutic Proteins Offer New Investment Opportunities
Seeking Alpha
Saturday, November 24, 2012 - 12:03pm
tags:
Prolor Biotech
5 Drug Hopefuls That Are Going to Change Your Life: Part 2
Motley Fool
Saturday, November 24, 2012 - 12:01pm
tags:
Gilead Sciences, sofosbuvir, hepatitis C, Bristol-Myers Squibb, BMS-986094, Idenix, IDX-184, Abbott Laboratories, Achillion, ACH-3102
Is Dendreon DOA in Europe?
Motley Fool
Saturday, November 24, 2012 - 11:39am
tags:
Dendreon
Has Achillion Pharmaceuticals Become the Perfect Stock?
Motley Fool
Saturday, November 24, 2012 - 11:39am
tags:
Achillion
Biogen Idec Inc: Today's Featured Health Care Winner
The Street
Saturday, November 24, 2012 - 11:38am
tags:
Biogen Idec
Good News for Vivus and Arena
Motley Fool
Saturday, November 24, 2012 - 11:37am
tags:
Vivus, Arena, weight loss, obesity
Risk Vs. Reward: 2 Biotech Stocks I'm Considering In The Wake Of Recent Developments
Seeking Alpha
Saturday, November 24, 2012 - 11:36am
tags:
Oxigene, Astex
Gilead Stock Hits New 52-Week High
The Street
Saturday, November 24, 2012 - 11:35am
tags:
Gilead Sciences
Sarepta Therapeutics: Tomorrow's Monster Stock
Motley Fool
Saturday, November 24, 2012 - 11:34am
tags:
Sarepta Therapeutics, eterplirsen, Duchenne Muscular Dystrophy, muscular dystrophy
Armed with EU stroke approval, Pfizer, BMS talk up Eliquis' edge over rivals
Fierce Pharma
Wednesday, November 21, 2012 - 12:28pm
tags:
Europe, stroke, Pfizer, Eliquis, bloodthinners, Bristol-Myers Squibb
Can InterMune Sustain Positive Momentum?
Seeking Alpha
Wednesday, November 21, 2012 - 12:17pm
tags:
InterMune
This Healthcare Giant Needs to Focus on Organic Growth
Motley Fool
Wednesday, November 21, 2012 - 11:21am
tags:
JNJ
Is There An Opportunity With Tranzyme After Stock Falls Over 75%?
Seeking Alpha
Wednesday, November 21, 2012 - 11:20am
tags:
Tranzyme
Revisiting Buyout Rumors After Teva's CEO Shifts Focus To 'Smaller Acquisitions'
Seeking Alpha
Wednesday, November 21, 2012 - 11:15am
tags:
Teva, M&A, Bristol-Myers Squibb, Eli Lilly, Novartis, Prolor, Pfizer
Impax signs development agreement with Perrigo
Yahoo/Fly on the Wall
Wednesday, November 21, 2012 - 11:11am
tags:
Perrigo, Impax Labs
Savient Pharma: Still Struggling To Grow KRYSTEXXA Sales
Seeking Alpha
Wednesday, November 21, 2012 - 10:44am
tags:
Savient, Krystexxa, gout
FDA approves Novartis cell culture flu vaccine
Pharma Times, UK
Wednesday, November 21, 2012 - 10:42am
tags:
FDA, Novartis, Flu, vaccines, Flucelvax
The Medicines Co. trades higher after analyst highlights company's pipeline
Yahoo/AP
Wednesday, November 21, 2012 - 10:41am
tags:
Medicines Company
Why Dynavax's HEPLISAV Is Likely To Be Approved: Impact On Future Vaccine Development
Seeking Alpha
Wednesday, November 21, 2012 - 10:40am
tags:
Dynavax, Heplisav, vaccines, FDA
Pfizer: Does it Need a Future Substitute for Lyrica?
Motley Fool
Wednesday, November 21, 2012 - 10:39am
tags:
Pfizer, Lyrica

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.